[go: up one dir, main page]

ES8406070A1 - Procedimiento para la fabricacion de la piperidindiona protectora del miocardio, con actividad antiarritmica - Google Patents

Procedimiento para la fabricacion de la piperidindiona protectora del miocardio, con actividad antiarritmica

Info

Publication number
ES8406070A1
ES8406070A1 ES527091A ES527091A ES8406070A1 ES 8406070 A1 ES8406070 A1 ES 8406070A1 ES 527091 A ES527091 A ES 527091A ES 527091 A ES527091 A ES 527091A ES 8406070 A1 ES8406070 A1 ES 8406070A1
Authority
ES
Spain
Prior art keywords
piperidindiona
miocardio
protective
procedure
manufacture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES527091A
Other languages
English (en)
Other versions
ES527091A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Publication of ES527091A0 publication Critical patent/ES527091A0/es
Publication of ES8406070A1 publication Critical patent/ES8406070A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57Nitriles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE PIPERIDINDIONAS DE FORMULA (I), EN LAS QUE N VALE 2 O 3; Y R Y R1-R5 PUEDEN SER VARIOS RADICALES; COMPUESTOS QUE TIENEN APLICACIONES FARMACOLOGICAS POR SU ACTIVIDAD ANTIARRITMICA.CONSISTE EN LA ALQUILACION DE PIRIDILACETONITRILO CON UN COMPUESTO DE FORMULA HAL(CH2)N-N(R)2, EN PRESENCIA DE UNA BASE; SEGUIDA DEL TRATAMIENTO CON UN NITRILO BAB- NO SATURADO DE FORMULA R1R2CFCR3CN, EN LAS QUE HAL ES HALOGENO Y LOS DEMAS SIMBOLOS SON LOS MISMOS QUE EN LA FORMULA (I). EL COMPUESTO OBTENIDO SE CICLA EN MEDIO ACIDO.
ES527091A 1982-11-08 1983-11-08 Procedimiento para la fabricacion de la piperidindiona protectora del miocardio, con actividad antiarritmica Expired ES8406070A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8218706A FR2535721A1 (fr) 1982-11-08 1982-11-08 Derives de la piperidinedione protecteurs du myocarde presentant une acticite antiarythmique, leur procede de preparation et les medicaments qui contiennent lesdits derives

Publications (2)

Publication Number Publication Date
ES527091A0 ES527091A0 (es) 1984-07-01
ES8406070A1 true ES8406070A1 (es) 1984-07-01

Family

ID=9279000

Family Applications (1)

Application Number Title Priority Date Filing Date
ES527091A Expired ES8406070A1 (es) 1982-11-08 1983-11-08 Procedimiento para la fabricacion de la piperidindiona protectora del miocardio, con actividad antiarritmica

Country Status (29)

Country Link
US (1) US4721710A (es)
EP (1) EP0110755B1 (es)
JP (1) JPS59161377A (es)
KR (1) KR900006721B1 (es)
AT (1) ATE22561T1 (es)
AU (1) AU565519B2 (es)
CA (1) CA1221967A (es)
CS (1) CS244681B2 (es)
DD (3) DD219770A5 (es)
DE (1) DE3366623D1 (es)
DK (1) DK511383A (es)
ES (1) ES8406070A1 (es)
FI (1) FI79536C (es)
FR (1) FR2535721A1 (es)
GR (1) GR78747B (es)
HU (1) HU191494B (es)
IE (1) IE56209B1 (es)
IL (1) IL70099A (es)
MA (1) MA19948A1 (es)
NO (1) NO159852C (es)
NZ (1) NZ206177A (es)
OA (1) OA07582A (es)
PH (1) PH20421A (es)
PL (3) PL140992B1 (es)
PT (1) PT77607B (es)
SG (1) SG1989G (es)
SU (3) SU1333237A3 (es)
YU (3) YU221183A (es)
ZA (1) ZA838065B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4668689A (en) * 1984-07-19 1987-05-26 National Research Development Corporation Glutarimide derivatives for treating oestrogen-dependent tumors
US5238947A (en) * 1990-04-12 1993-08-24 University Of Georgia Research Foundation, Inc. Synthetic piperidinediones with cytostatic activity
US5463063A (en) * 1993-07-02 1995-10-31 Celgene Corporation Ring closure of N-phthaloylglutamines
DE19703763C1 (de) * 1997-02-01 1998-10-01 Gruenenthal Gmbh Thalidomidanaloge Verbindungen aus der Klasse der Piperidin-2,6-Dione
JP5974084B2 (ja) 2011-05-17 2016-08-23 プリンシピア バイオファーマ インコーポレイテッド チロシンキナーゼ阻害剤
KR102052670B1 (ko) 2011-05-17 2019-12-06 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 키나아제 저해제
US9376438B2 (en) 2011-05-17 2016-06-28 Principia Biopharma, Inc. Pyrazolopyrimidine derivatives as tyrosine kinase inhibitors
SMT201900344T1 (it) 2012-09-10 2019-07-11 Principia Biopharma Inc Composti di pirazolopirimidina come inibitori di chinasi
US8957080B2 (en) 2013-04-09 2015-02-17 Principia Biopharma Inc. Tyrosine kinase inhibitors
BR112016018948B1 (pt) 2014-02-21 2023-01-17 Principia Biopharma Inc Uso de composto ou sal farmaceuticamente aceitável, ácido sulfônico ou sal de ácido carboxílico de composto, forma amorfa de sal farmaceuticamente aceitável de composto, composição farmacêutica e respectivo uso
EP3233103B1 (en) 2014-12-18 2020-10-14 Principia Biopharma Inc. Treatment of pemphigus
MA42242A (fr) 2015-06-24 2018-05-02 Principia Biopharma Inc Inhibiteurs de la tyrosine kinase
CN115054586B (zh) 2016-06-29 2024-08-02 普林斯匹亚生物制药公司 改性的释放制剂
IL291994A (en) 2019-10-14 2022-06-01 Principia Biopharma Inc Methods for treating immune thrombocytopenia by administering (r)-2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2664424A (en) * 1953-12-29 Dioxo-piperidines
GB1455687A (en) * 1972-12-28 1976-11-17 Aspro Nicholas Ltd Pharmacologically active 3-phenyl-3-aminoalkyl-2,6-dioxo-hydro genated pyridines
FR2467200A1 (fr) * 1979-10-11 1981-04-17 Clin Midy Derives du pyrrole actifs sur les troubles du rythme cardiovasculaire

Also Published As

Publication number Publication date
YU221183A (en) 1986-06-30
FI79536B (fi) 1989-09-29
NO159852B (no) 1988-11-07
FR2535721B1 (es) 1985-05-17
MA19948A1 (fr) 1984-07-01
PT77607A (fr) 1983-12-01
PH20421A (en) 1987-01-05
CA1221967A (en) 1987-05-19
EP0110755B1 (fr) 1986-10-01
KR900006721B1 (ko) 1990-09-20
HU191494B (en) 1987-02-27
PL244462A1 (en) 1985-02-13
ZA838065B (en) 1984-06-27
ES527091A0 (es) 1984-07-01
DK511383D0 (da) 1983-11-08
SU1333238A3 (ru) 1987-08-23
ATE22561T1 (de) 1986-10-15
NO834057L (no) 1984-05-09
DD229407A5 (de) 1985-11-06
IE56209B1 (en) 1991-05-22
PT77607B (fr) 1986-03-18
SU1333237A3 (ru) 1987-08-23
AU565519B2 (en) 1987-09-17
DK511383A (da) 1984-05-09
IL70099A0 (en) 1984-01-31
DE3366623D1 (en) 1986-11-06
SG1989G (en) 1989-06-02
FI834087L (fi) 1984-05-09
SU1316558A3 (ru) 1987-06-07
FI834087A0 (fi) 1983-11-08
YU184285A (en) 1986-06-30
YU184185A (en) 1986-06-30
PL140992B1 (en) 1987-06-30
OA07582A (fr) 1985-03-31
DD229402A5 (de) 1985-11-06
PL140021B1 (en) 1987-03-31
FI79536C (fi) 1990-01-10
FR2535721A1 (fr) 1984-05-11
AU2089883A (en) 1984-05-17
IE832581L (en) 1984-05-08
NO159852C (no) 1989-02-15
NZ206177A (en) 1985-11-08
CS244681B2 (en) 1986-08-14
PL249750A1 (en) 1985-03-12
DD219770A5 (de) 1985-03-13
JPS59161377A (ja) 1984-09-12
EP0110755A1 (fr) 1984-06-13
PL139946B1 (en) 1987-03-31
PL249749A1 (en) 1985-03-12
KR840006641A (ko) 1984-12-01
US4721710A (en) 1988-01-26
IL70099A (en) 1987-10-20
GR78747B (es) 1984-10-02

Similar Documents

Publication Publication Date Title
ES8406070A1 (es) Procedimiento para la fabricacion de la piperidindiona protectora del miocardio, con actividad antiarritmica
ES525786A0 (es) Un procedimiento para preparar derivados de pirazolo (3,4-b) piridina
IL61285A0 (en) 2-hydroxyalkyl-3,4,k-trihydroxy-piperidine compounds, their production and pharmaceutical compositions containing them
IL73320A0 (en) Purine derivatives and pharmaceutical compositions containing them
ES8706148A1 (es) Un procedimiento para preparar nuevos derivados de carbapenem.
IT7827850A0 (it) Composizioni stabilizzate alla luce uv, contenenti 1,5-diazacicloalcani e 2-cheto-1,5-diazacicloalcani sostituiti come composti di nuovo tipo e sintesi di tali composti.
DE68922344D1 (de) Herstellung von Enantiomeren des Dropropizins.
HUT39445A (en) Herbicides containing as reagent derivatives of benzodisultam and process for production of the reagents
JPS57200370A (en) 1-acyl group substituted-4-hydroxyalkylhomopiperazine derivative
ES8305748A1 (es) Procedimiento para la obtencion de sulfenamidas.
ATE23340T1 (de) 3-alkylthio-2-0-carbamoylpropan-1,2-diol-1-0phosphocholine und verfahren zu ihrer herstellung.
HU905030D0 (en) Process for producing new 1,3-oxazines and pharmaceutical preparatives containing these compounds
SE8106359L (sv) 5,6,7,8-tetrahydro-1,6-naftyridinderivat och sett att framstella desamma
ES8402821A1 (es) Procedimiento de obtencion de las feniloxoalcoil piperidinas.
JPS53124277A (en) 1-substed-(1,2-diphenylpropyl)piperazines
ATE108783T1 (de) 2-imino-6-polyfluoralkyl-3-heterocyclylalkyl- benzothiazolinderivate, ihre herstellung und sie enthaltende arzneimittel.